Industry

AMA supports insurance coverage for myopia treatment

Healio Optometry2d ago1 min read

The AMA has adopted a resolution supporting insurance reimbursement for myopia treatment, saying the condition is a significant public health concern and should be formally classified as “a disease” by CMS.This comes as the FDA approves an increasing array of options for reducing myopia and slowing its progression, including spectacle and contact lenses. The global prevalence of myopia has been forecasted to reach 50% by 2050.The resolution, adopted by AMA’s House of Delegates in June, says that AMA supports “efforts to ensure comprehensive insurance coverage and reimbursement for

Read full article on Healio Optometry

AI Summary

Quick Take

The American Medical Association (AMA) has adopted a resolution supporting comprehensive insurance coverage and reimbursement for myopia treatment, urging CMS to formally classify the condition as a "disease." This move aligns with the growing availability of FDA-approved interventions, such as specialized spectacle and contact lenses, designed to slow progression in a population where global prevalence is projected to hit 50% by 2050.

Why It Matters

For years, myopia management has been largely a private-pay specialty, creating a significant financial barrier for many families. By pushing for a formal disease classification from CMS, the AMA is signaling a shift from viewing myopia as a simple refractive error to recognizing it as a progressive pathology with long-term ocular health risks. If insurance carriers follow this lead, it could fundamentally change the economics of pediatric eye care, making advanced treatments accessible to a much broader patient demographic and moving myopia control into the standard of care.

Key Details

The AMA House of Delegates adopted the resolution in June, advocating for efforts to ensure comprehensive insurance coverage for myopia treatments.
The resolution specifically calls for the Centers for Medicare & Medicaid Services (CMS) to formally classify myopia as a disease.
The policy shift is supported by the increasing number of FDA-approved options for slowing myopia progression, including both contact lenses and spectacle lenses.
The AMA cited the significant public health impact of the condition, noting that global myopia prevalence is forecasted to reach 50% by 2050.

Practice Implications

Clinicians should monitor for updates to CMS classification, as a shift to medical coverage would require more robust documentation of progression and medical necessity. Practice owners may eventually need to transition their myopia management billing workflows from elective, out-of-pocket models to traditional medical insurance reimbursement structures.

Who's Affected

Pediatric OptometristsOphthalmologistsPractice OwnersContact Lens FittersBilling and Coding Specialists

What's Next

The industry will be watching for a response from CMS regarding the reclassification of myopia. If adopted, this change would likely trigger a revision of coverage policies among private insurers, potentially expanding patient access to myopia control devices and services over the coming years.

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.